Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Marinol effect on transient lower esophageal sphincter relaxations
NL-OMON21968Active, not recruiting
- Start
- May 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of dronabinol in gastroesophageal reflux disease (GERD) (2 arms). Primary endpoint: Frequency of transient lower esophageal sphincter relaxations. Started May 2004; status: active, not recruiting.
02
Drugs
dronabinol
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NL-OMON21968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21968.